References
Adler, M., A. Mayo, X. Zhou, R. A. Franklin, J. B. Jacox, R. Medzhitov, and U. Alon. 2018. Endocytosis as a stabilizing mechanism for tissue homeostasis. Proceedings of the National Academy of Sciences of the United States of America 115(8):E1926–E1935.
Amor, C., J. Feucht, J. Leibold, Y. J. Ho, C. Zhu, D. Alonso-Curbelo, J. Mansilla-Soto, J. A. Boyer, X. Li, T. Giavridis, A. Kulick, S. Houlihan, E. Peerschke, S. L. Friedman, V. Ponomarev, A. Piersigilli, M. Sadelain, and S. W. Lowe. 2020. Senolytic CAR T cells reverse senescence-associated pathologies. Nature 583(7814):127–132.
Anderson, J. M., A. Rodriguez, and D. T. Chang. 2008. Foreign body reaction to biomaterials. Seminars in Immunology 20(2):86–100.
Arnardottir, H. H., J. Dalli, R. A. Colas, M. Shinohara, and C. N. Serhan. 2014. Aging delays resolution of acute inflammation in mice: Reprogramming the host response with novel nano-proresolving medicines. Journal of Immunology 193(8):4235–4244.
Badylak, S. F., J. E. Valentin, A. K. Ravindra, G. P. McCabe, and A. M. Stewart-Akers. 2008. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Engineering Part A 14(11):1835–1842.
Bellantuono, I. 2018. Find drugs that delay many diseases of old age. Nature 554(7692):293–295.
Bemelman, F., K. Honey, E. Adams, S. Cobbold, and H. Waldmann. 1998. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. Journal of Immunology 160(6):2645–2648.
Bhate, S. S., G. L. Barlow, C. M. Schürch, and G. P. Nolan. 2021. Tissue schematics map the specialization of immune tissue motifs and their appropriation by tumors. Cell Systems.
Bigenzahn, S., P. Blaha, Z. Koporc, I. Pree, E. Selzer, H. Bergmeister, F. Wrba, C. Heusser, K. Wagner, F. Muehlbacher, and T. Wekerle. 2005. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. American Journal of Transplantation 5(6):1237–1247.
Blau, H. M., B. D. Cosgrove, and A. T. Ho. 2015. The central role of muscle stem cells in regenerative failure with aging. Nature Medicine 21(8):854–862.
Boberg, E., L. von Bahr, G. Afram, C. Lindstrom, P. Ljungman, N. Heldring, P. Petzelbauer, K. Garming Legert, N. Kadri, and K. Le Blanc. 2020. Treatment of chronic GVHD with mesenchymal stromal cells induces durable responses: A phase II study. Stem Cells Translational Medicine 9(10):1190–1202.
Botelho, J., V. Machado, Y. Leira, L. Proenca, L. Chambrone, and J. J. Mendes. 2021. Economic burden of periodontitis in the United States and Europe—An updated estimation. Journal of Periodontology: 1-7.
Brentjens, R. J., M. L. Davila, I. Riviere, J. Park, X. Wang, L. G. Cowell, S. Bartido, J. Stefanski, C. Taylor, M. Olszewska, O. Borquez-Ojeda, J. Qu, T. Wasielewska, Q. He, Y. Bernal, I. V. Rijo, C. Hedvat, R. Kobos, K. Curran, P. Steinherz, J. Jurcic, T. Rosenblat, P. Maslak, M. Frattini, and M. Sadelain. 2013. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Science Translational Medicine 5(177):177ra138.
Brentjens, R. J., J.-B. Latouche, E. Santos, F. Marti, M. C. Gong, C. Lyddane, P. D. King, S. Larson, M. Weiss, I. Rivière, and M. Sadelain. 2003. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nature Medicine 9(3):279–286.
Browne, S., and A. Pandit. 2015. Biomaterial-mediated modification of the local inflammatory environment. Frontiers in Bioengineering and Biotechnology 3(67):67.
Burns, E. R., J. A. Stevens, and R. Lee. 2016. The direct costs of fatal and non-fatal falls among older adults—United States. Journal of Safety Research 58:99–103.
Chen, X., L. Poncette, and T. Blankenstein. 2017. Human TCR-MHC coevolution after divergence from mice includes increased nontemplate-encoded CDR3 diversity. Journal of Experimental Medicine 214(11):3417–3433.
Cheng, A., C. E. Vantucci, L. Krishnan, M. A. Ruehle, T. Kotanchek, L. B. Wood, K. Roy, and R. E. Guldberg. 2021. Early systemic immune biomarkers predict bone regeneration after trauma. Proceedings of the National Academy of Sciences of the United States of America 118(8).
Cherry, C., D. R. Maestas, J. Han, J. I. Andorko, P. Cahan, E. J. Fertig, L. X. Garmire, and J. H. Elisseeff. 2021. Computational reconstruction of the signalling networks surrounding implanted biomaterials from single-cell transcriptomics. Nature Biomedical Engineering 5(10):1228–1238.
Chiang, N., X. de la Rosa, S. Libreros, H. Pan, J. M. Dreyfuss, and C. N. Serhan. 2021. Cysteinyl-specialized proresolving mediators link resolution of infectious inflammation and tissue regeneration via TRAF3 activation. Proceedings of the National Academy of Sciences of the United States of America 118(10):e2013374118.
Chiurchiu, V., A. Leuti, J. Dalli, A. Jacobsson, L. Battistini, M. Maccarrone, and C. N. Serhan. 2016. Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Science Translational Medicine 8(353):353ra111.
Choi, E. Y., E. Chavakis, M. A. Czabanka, H. F. Langer, L. Fraemohs, M. Economopoulou, R. K. Kundu, A. Orlandi, Y. Y. Zheng, D. A. Prieto, C. M. Ballantyne, S. L. Constant, W. C. Aird, T. Papayannopoulou, C. G. Gahmberg, M. C. Udey, P. Vajkoczy, T. Quertermous, S. Dimmeler, C. Weber, and T. Chavakis. 2008. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 322(5904):1101–1104.
Choi, E. Y., J. H. Lim, A. Neuwirth, M. Economopoulou, A. Chatzigeorgiou, K. J. Chung, S. Bittner, S. H. Lee, H. Langer, M. Samus, H. Kim, G. S. Cho, T. Ziemssen, K. Bdeir, E. Chavakis, J. Y. Koh, L. Boon, K. Hosur, S. R. Bornstein, S. G. Meuth, G. Hajishengallis, and T. Chavakis. 2015. Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. Molecular Psychiatry 20(7):880–888.
Chung, L., D. R. Maestas, Jr., A. Lebid, A. Mageau, G. D. Rosson, X. Wu, M. T. Wolf, A. J. Tam, I. Vanderzee, X. Wang, J. I. Andorko, H. Zhang, R. Narain, K. Sadtler, H. Fan, D. Cihakova, C. J. Le Saux, F. Housseau, D. M. Pardoll, and J. H. Elisseeff. 2020. Interleukin 17 and senescent cells regulate the foreign body response to synthetic material implants in mice and humans. Science Translational Medicine 12(539):eaax3799.
Cianci, E., A. Recchiuti, O. Trubiani, F. Diomede, M. Marchisio, S. Miscia, R. A. Colas, J. Dalli, C. N. Serhan, and M. Romano. 2016. Human periodontal stem cells release specialized proresolving mediators and carry immunomodulatory and prohealing properties regulated by lipoxins. Stem Cells Translational Medicine 5(1):20–32.
Couzin-Frankel, J. 2013. Breakthrough of the year 2013. Cancer immunotherapy. Science 342(6165):1432–1433.
Dalli, J., N. Chiang, and C. N. Serhan. 2014. Identification of 14-series sulfido-conjugated mediators that promote resolution of infection and organ protection. Proceedings of the National Academy of Sciences of the United States of America 111(44):E4753–4761.
de la Rosa, X., P. C. Norris, N. Chiang, A. R. Rodriguez, B. W. Spur, and C. N. Serhan. 2018. Identification and complete stereochemical assignments of the new resolvin conjugates in tissue regeneration in human tissues that stimulate proresolving phagocyte functions and tissue regeneration. American Journal of Pathology 188(4):950–966.
de Witte, S. F. H., A. M. Merino, M. Franquesa, T. Strini, J. A. A. van Zoggel, S. S. Korevaar, F. Luk, M. Gargesha, L. O’Flynn, D. Roy, S. J. Elliman, P. N. Newsome, C. C. Baan, and M. J. Hoogduijn. 2017. Cytokine treatment optimises the immunotherapeutic effects of umbilical cord-derived MSC for treatment of inflammatory liver disease. Stem Cell Research & Therapy 8(1):140.
Deuse, T., X. Hu, S. Agbor-Enoh, M. K. Jang, M. Alawi, C. Saygi, A. Gravina, G. Tediashvili, V. Q. Nguyen, Y. Liu, H. Valantine, L. L. Lanier, and S. Schrepfer. 2021a. The SIRP – CD47 immune checkpoint in NK cells. Journal of Experimental Medicine 218(3).
Deuse, T., X. Hu, S. Agbor-Enoh, M. Koch, M. H. Spitzer, A. Gravina, M. Alawi, A. Marishta, B. Peters, Z. Kosaloglu-Yalcin, Y. Yang, R. Rajalingam, D. Wang, B. Nashan, R. Kiefmann, H. Reichenspurner, H. Valantine, I. L. Weissman, and S. Schrepfer. 2019. De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans. Nature Biotechnology 37(10):1137–1144.
Deuse, T., G. Tediashvili, X. Hu, A. Gravina, A. Tamenang, D. Wang, A. Connolly, C. Mueller, B. Mallavia, M. R. Looney, M. Alawi, L. L. Lanier, and S. Schrepfer. 2021b. Hypoimmune induced pluripotent stem cell-derived cell therapeutics treat cardiovascular and pulmonary diseases in immunocompetent allogeneic mice. Proceedings of the National Academy of Sciences of the United States of America 118(28).
Deuse, T., D. Wang, M. Stubbendorff, R. Itagaki, A. Grabosch, L. C. Greaves, M. Alawi, A. Grunewald, X. Hu, X. Hua, J. Velden, H. Reichenspurner, R. C. Robbins, R. Jaenisch, I. L. Weissman, and S. Schrepfer. 2015. SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts. Cell Stem Cell 16(1):33–38.
Doloff, J. C., O. Veiseh, A. J. Vegas, H. H. Tam, S. Farah, M. Ma, J. Li, A. Bader, A. Chiu, A. Sadraei, S. Aresta-Dasilva, M. Griffin, S. Jhunjhunwala, M. Webber, S. Siebert, K. Tang, M. Chen, E. Langan, N. Dholokia, R. Thakrar, M. Qi, J. Oberholzer, D. L. Greiner, R. Langer, and D. G. Anderson. 2017. Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primates. Nature Materials 16(6):671–680.
Domenig, C., A. Sanchez-Fueyo, J. Kurtz, S. P. Alexopoulos, C. Mariat, M. Sykes, T. B. Strom, and X. X. Zheng. 2005. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. Journal of Immunology 175(1):51–60.
Dort, J., Z. Orfi, P. Fabre, T. Molina, T. C. Conte, K. Greffard, O. Pellerito, J. F. Bilodeau, and N. A. Dumont. 2021. Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy. Nature Communications 12(1):6264.
Duran-Struuck, R., H. P. Sondermeijer, L. Buhler, P. Alonso-Guallart, J. Zitsman, Y. Kato, A. Wu, A. N. McMurchy, D. Woodland, A. Griesemer, M. Martinez, S. Boskovic, T. Kawai, A. B. Cosimi, Y. G. Yang, Z. Hu, C. S. Wuu, A. Slate, M. Mapara, S. Baker, R. Tokarz, V. D’Agati, S. Hammer, M. Pereira, W. I. Lipkin, T. Wekerle, M. Levings, and M. Sykes. 2017. Effect of ex vivo-expanded recipient regulatory T cells on hematopoietic chimerism and kidney allograft tolerance across MHC barriers in cynomolgus macaques. Transplantation 101(2):274–283.
Eskan, M. A., R. Jotwani, T. Abe, J. Chmelar, J. H. Lim, S. Liang, P. A. Ciero, J. L. Krauss, F. Li, M. Rauner, L. C. Hofbauer, E. Y. Choi, K. J. Chung, A. Hashim, M. A. Curtis, T. Chavakis, and G. Hajishengallis. 2012. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nature Immunology 13(5):465–473.
Faust, H. J., H. Zhang, J. Han, M. T. Wolf, O. H. Jeon, K. Sadtler, A. N. Pena, L. Chung, D. R. Maestas, Jr., A. J. Tam, D. M. Pardoll, J. Campisi, F. Housseau, D. Zhou, C. O. Bingham, 3rd, and J. H. Elisseeff. 2020. IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis. Journal of Clinical Investigation 130(10):5493–5507.
Fehr, T., F. Haspot, J. Mollov, M. Chittenden, T. Hogan, and M. Sykes. 2008. Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II. Journal of Immunology 181(1):165–173.
Fehr, T., C. L. Lucas, J. Kurtz, T. Onoe, G. Zhao, T. Hogan, C. Vallot, A. Rao, and M. Sykes. 2010. A CD8 T cell–intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo. Blood 115(6):1280–1287.
Fehr, T., Y. Takeuchi, J. Kurtz, T. Wekerle, and M. Sykes. 2005. Early regulation of CD8 T cell alloreactivity by CD4+CD25− T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation. European Journal of Immunology 35(9):2679–2690.
Galleu, A., Y. Riffo-Vasquez, C. Trento, C. Lomas, L. Dolcetti, T. S. Cheung, M. von Bonin, L. Barbieri, K. Halai, S. Ward, L. Weng, R. Chakraverty, G. Lombardi, F. M. Watt, K. Orchard, D. I. Marks, J. Apperley, M. Bornhauser, H. Walczak, C. Bennett, and F. Dazzi. 2017. Apoptosis in mesenchymal stromal cells induces in vivo recipient–mediated immunomodulation. Science Translational Medicine 9(416).
Gaudilliere, B., G. K. Fragiadakis, R. V. Bruggner, M. Nicolau, R. Finck, M. Tingle, J. Silva, E. A. Ganio, C. G. Yeh, W. J. Maloney, J. I. Huddleston, S. B. Goodman, M. M. Davis, S. C. Bendall, W. J. Fantl, M. S. Angst, and G. P. Nolan. 2014. Clinical recovery from surgery correlates with single-cell immune signatures. Science Translational Medicine 6(255):255ra131.
Gavin, C., E. Boberg, L. Von Bahr, M. Bottai, A. T. Andren, A. Wernerson, L. C. Davies, R. V. Sugars, and K. Le Blanc. 2019a. Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease-a gut feeling. Stem Cell Research & Therapy 10(1):334.
Gavin, C., S. Meinke, N. Heldring, K. A. Heck, A. Achour, E. Iacobaeus, P. Hoglund, K. Le Blanc, and N. Kadri. 2019b. The complement system is essential for the phagocytosis of mesenchymal stromal cells by monocytes. Frontiers in Immunology 10:2249.
Globerson Levin, A., I. Riviere, Z. Eshhar, and M. Sadelain. 2021. CAR T cells: Building on the CD19 paradigm. European Journal of Immunology 51(9):2151–2163.
Goltsev, Y., N. Samusik, J. Kennedy-Darling, S. Bhate, M. Hale, G. Vazquez, S. Black, and G. P. Nolan. 2018. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174(4):968–981 e915.
Goncalves, F. D. C., F. Luk, S. S. Korevaar, R. Bouzid, A. H. Paz, C. Lopez-Iglesias, C. C. Baan, A. Merino, and M. J. Hoogduijn. 2017. Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes. Scientific Reports 7(1):12100.
Gregoire, C., C. Ritacco, M. Hannon, L. Seidel, L. Delens, L. Belle, S. Dubois, S. Veriter, C. Lechanteur, A. Briquet, S. Servais, G. Ehx, Y. Beguin, and F. Baron. 2019. Comparison of mesenchymal stromal cells from different origins for the treatment of graft-vs.-host-disease in a humanized mouse model. Frontiers in Immunology 10:619.
Hachim, D., S. T. Lopresti, C. C. Yates, and B. N. Brown. 2017. Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration. Biomaterials 112:95–107.
Hajishengallis, G., and T. Chavakis. 2021. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nature Reviews Immunology 21(7):426–440.
Han, J., C. Cherry, A. Ruta, D. R. Maestas, J. C. Mejias, H. H. Nguyen, E. J. Fertig, F. Housseau, S. Ganguly, E. M. Moore, A. J. Tam, D. M. Pardoll, and J. H. Elisseeff. 2021 (unpublished). Age-related immune-stromal networks inhibit response to regenerative immunotherapies. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
Haspot, F., T. Fehr, C. Gibbons, G. Zhao, T. Hogan, T. Honjo, G. J. Freeman, and M. Sykes. 2008. Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway. Blood 112(5):2149–2155.
Hasturk, H., G. Hajishengallis, Forsyth Institute Center for Translational Research staff, J. D. Lambris, D. C. Mastellos, and D. Yancopoulou. 2021. Phase IIa clinical trial of complement C3 inhibitor AMY-101 in adults with periodontal inflammation. Journal of Clinical Investigation 131(23).
Hayase, E., T. Hayase, C.-C. Chang, T. Miyama, J. L. Karmouch, W.-B. Tsai, M. A. Jamal, and R. R. Jenq. 2021. Carbapenem antibiotics promote mucus degradation by bacteroides and aggravate graft-versus-host disease. Blood 138(Supplement 1):85–85.
Heredia, J. E., L. Mukundan, F. M. Chen, A. A. Mueller, R. C. Deo, R. M. Locksley, T. A. Rando, and A. Chawla. 2013. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153(2):376–388.
Hickey, J. W., E. K. Neumann, A. J. Radtke, J. M. Camarillo, R. T. Beuschel, A. Albanese, E. McDonough, J. Hatler, A. E. Wiblin, J. Fisher, J. Croteau, E. C. Small, A. Sood, R. M. Caprioli, R. M. Angelo, G. P. Nolan, K. Chung, S. M. Hewitt, R. N. Germain, J. M. Spraggins, E. Lundberg, M. P. Snyder, N. L. Kelleher, and S. K. Saka. 2021. Spatial mapping of protein composition and tissue organization: A primer for multiplexed antibody-based imaging. Nature Methods: 1-12.
Hickson, L. J., L. G. P. Langhi Prata, S. A. Bobart, T. K. Evans, N. Giorgadze, S. K. Hashmi, S. M. Herrmann, M. D. Jensen, Q. Jia, K. L. Jordan, T. A. Kellogg, S. Khosla, D. M. Koerber, A. B. Lagnado, D. K. Lawson, N. K. Lebrasseur, L. O. Lerman, K. M. McDonald, T. J. McKenzie, J. F. Passos, R. J. Pignolo, T. Pirtskhalava, I. M. Saadiq, K. K. Schaefer, S. C. Textor, S. G. Victorelli, T. L. Volkman, A. Xue, M. A. Wentworth, E. O. Wissler Gerdes, Y. Zhu, T. Tchkonia, and J. L. Kirkland. 2019. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine 47:446–456.
Hillel, A. T., S. Unterman, Z. Nahas, B. Reid, J. M. Coburn, J. Axelman, J. J. Chae, Q. Guo, R. Trow, A. Thomas, Z. Hou, S. Lichtsteiner, D. Sutton, C. Matheson, P. Walker, N. David, S. Mori, J. M. Taube, and J. H. Elisseeff. 2011. Photoactivated composite biomaterial for soft tissue restoration in rodents and in humans. Science Translational Medicine 3(93):93ra67.
Ho, A. T. V., A. R. Palla, M. R. Blake, N. D. Yucel, Y. X. Wang, K. E. G. Magnusson, C. A. Holbrook, P. E. Kraft, S. L. Delp, and H. M. Blau. 2017. Prostaglandin E2 is essential for efficacious skeletal muscle stem-cell function, augmenting regeneration and strength. Proceedings of the National Academy of Sciences of the United States of America 114(26):6675–6684.
Ho, Y. T., T. Shimbo, E. Wijaya, Y. Ouchi, E. Takaki, R. Yamamoto, Y. Kikuchi, Y. Kaneda, and K. Tamai. 2018. Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins. Scientific Reports 8(1):17765.
Hollyman, D., J. Stefanski, M. Przybylowski, S. Bartido, O. Borquez-Ojeda, C. Taylor, R. Yeh, V. Capacio, M. Olszewska, J. Hosey, M. Sadelain, R. J. Brentjens, and I. Riviere. 2009. Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. Journal of Immunotherapy 32(2):169–180.
Hu, X., M. Dao, K. White, R. Clarke, S. Landry, R. Basco, C. Gattis, E. Tham, E. Luo, A. Tucker, C. Bandoro, E. Chu, J. Kim, C. Young, W. E. Dowdle, E. J. Rebar, T. J. Fry, and S. Schrepfer. 2021. Abstract LB144: Overexpression of CD47 protects hypoimmune CAR T cells from innate immune cell killing. Cancer Research 81(13 Supplement):LB144.
Hunt, D., D. W. Chapa, B. Hess, K. Swanick, and A. Hovanec. 2015. The importance of resistance training in the treatment of sarcopenia. Journal of Nursing Education and Practice 5(3):39–43. doi: 10.5430/jnep.v5n3p39.
Iske, J., M. Seyda, T. Heinbokel, R. Maenosono, K. Minami, Y. Nian, M. Quante, C. S. Falk, H. Azuma, F. Martin, J. F. Passos, C. U. Niemann, T. Tchkonia, J. L. Kirkland, A. Elkhal, and S. G. Tullius. 2020. Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation. Nature Commununications 11(1):4289.
Iwata, Y., A. Yoshizaki, K. Komura, K. Shimizu, F. Ogawa, T. Hara, E. Muroi, S. Bae, M. Takenaka, T. Yukami, M. Hasegawa, M. Fujimoto, Y. Tomita, T. F. Tedder, and S. Sato. 2009. CD19, a response regulator of B lymphocytes, regulates wound healing through hyaluronan-induced TLR4 signaling. American Journal of Pathology 175(2):649–660.
Jagasia, M., A. Lazaryan, C. R. Bachier, A. Salhotra, D. J. Weisdorf, B. Zoghi, J. Essell, L. Green, O. Schueller, J. Patel, A. Zanin-Zhorov, J. M. Weiss, Z. Yang, D. Eiznhamer, S. K. Aggarwal, B. R. Blazar, and S. J. Lee. 2021. ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease. Journal of Clinical Oncology 39(17):1888–1898.
Janeway, C. A., P. Travers, M. Walport, and M. Shlomchik. 2001. Immunobiology: The immune system in health and disease, 5th ed. New York: Garland Science.
Jenq, R. R., and M. R. van den Brink. 2010. Allogeneic haematopoietic stem cell transplantation: Individualized stem cell and immune therapy of cancer. Nature Reviews Cancer 10(3):213–221.
Jing, Y., Z. Ni, J. Wu, L. Higgins, T. W. Markowski, D. S. Kaufman, and B. Walcheck. 2015. Identification of an ADAM17 cleavage region in human CD16 (Fc RIII) and the engineering of a non-cleavable version of the receptor in NK cells. PLOS ONE 10(3):e0121788.
Jones, J. M., R. Wilson, and P. M. Bealmear. 1971. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiation Research 45(3):577–588.
Julier, Z., A. J. Park, P. S. Briquez, and M. M. Martino. 2017. Promoting tissue regeneration by modulating the immune system. Acta Biomaterialia 53:13–28.
Jun, J. I., and L. F. Lau. 2011. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nature Reviews Drug Discovery 10(12):945-963.
June, C. H., and M. Sadelain. 2018. Chimeric antigen receptor therapy. The New England Journal of Medicine 379(1):64–73.
Kasikis, S., J. Baez, I. Gandhi, S. Grupp, C. L. Kitko, S. Kowalyk, P. Merli, G. Morales, M. A. Pulsipher, M. Qayed, M. Wolfl, G. Yanik, F. See, J. Hayes, F. Grossman, E. Burke, R. Young, J. E. Levine, and J. L. M. Ferrara. 2021. Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers. Bone Marrow Transplantation 56(11):2869–2870.
Kasler, H., and E. Verdin. 2021. How inflammaging diminishes adaptive immunity. Nature Aging 1(1):24–25.
Kassebaum, N. J., E. Bernabe, M. Dahiya, B. Bhandari, C. J. Murray, and W. Marcenes. 2014. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. Journal of Dental Research 93(11):1045–1053.
Kawai, T., A. B. Cosimi, T. R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S. L. Saidman, J. Shaffer, F. I. Preffer, R. Ding, V. Sharma, J. A. Fishman, B. Dey, D. S. C. Ko, M. Hertl, N. B. Goes, W. Wong, W. W. Williams, Jr., R. B. Colvin, M. Sykes, and D. H. Sachs. 2008. HLA-mismatched renal transplantation without maintenance immunosuppression. The New England Journal of Medicine 358(4):353–361. https://doi.org/10.1056/NEJMoa071074.
Kawai, T., D. H. Sachs, M. Sykes, A. B. Cosimi, and Immune Tolerance Network. 2013. HLA-mismatched renal transplantation without maintenance immunosuppression. The New England Journal of Medicine 368(19):1850–1852. https://doi.org/10.1056/NEJMc1213779.
Kawamura, T., S. Miyagawa, S. Fukushima, A. Maeda, N. Kashiyama, A. Kawamura, K. Miki, K. Okita, Y. Yoshida, T. Shiina, K. Ogasawara, S. Miyagawa, K. Toda, H. Okuyama, and Y. Sawa. 2016. Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates. Stem Cell Reports 6(3):312–320.
Kehl, D., M. Generali, A. Mallone, M. Heller, A. C. Uldry, P. Cheng, B. Gantenbein, S. P. Hoerstrup, and B. Weber. 2019. Proteomic analysis of human mesenchymal stromal cell secretomes: A systematic comparison of the angiogenic potential. NPJ Regenerative Medicine 4:8.
Khan, A., Y. Tomita, and M. Sykes. 1996. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 62(3):380–387.
Kourtzelis, I., X. Li, I. Mitroulis, D. Grosser, T. Kajikawa, B. Wang, M. Grzybek, J. von Renesse, A. Czogalla, M. Troullinaki, A. Ferreira, C. Doreth, K. Ruppova, L. S. Chen, K. Hosur, J. H. Lim, K. J. Chung, S. Grossklaus, A. K. Tausche, L. A. B. Joosten, N. M. Moutsopoulos, B. Wielockx, A. Castrillo, J. M. Korostoff, U. Coskun, G. Hajishengallis, and T. Chavakis. 2019. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nature Immunology 20(1):40–49.
Krampera, M., and K. Le Blanc. 2021. Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy. Cell Stem Cell 28(10):1708–1725.
Krishnamurthy, J., C. Torrice, M. R. Ramsey, G. I. Kovalev, K. Al-Regaiey, L. Su, and N. E. Sharpless. 2004. Ink4a/Arf expression is a biomarker of aging. Journal of Clinical Investigation 114(9):1299–1307.
Kurtz, J., J. Shaffer, A. Lie, N. Anosova, G. Benichou, and M. Sykes. 2004. Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: Evidence for anergy and deletion but not regulatory cells. Blood 103(11):4336–4343.
Le Blanc, K., and D. Mougiakakos. 2012. Multipotent mesenchymal stromal cells and the innate immune system. Nature Reviews Immunology 12(5):383–396.
Li, Y., D. L. Hermanson, B. S. Moriarity, and D. S. Kaufman. 2018. Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity. Cell Stem Cell 23(2):181–192.e185.
LoCascio, S. A., T. Morokata, M. Chittenden, F. I. Preffer, D. M. Dombkowski, G. Andreola, K. Crisalli, T. Kawai, S. L. Saidman, T. R. Spitzer, N. Tolkoff-Rubin, A. B. Cosimi, D. H. Sachs, and M. Sykes. 2010. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation 90(12):1607–1615.
Looker, A. C., C.-Y. Wang. 2015. Prevalence of reduced muscle strength in older U.S. adults: United States, 2011–2012. NCHS data brief no. 179. Hyattsville, MD: National Center for Health Statistics.
Lu, S., J. E. Stein, D. L. Rimm, D. W. Wang, J. M. Bell, D. B. Johnson, J. A. Sosman, K. A. Schalper, R. A. Anders, H. Wang, C. Hoyt, D. M. Pardoll, L. Danilova, and J. M. Taube. 2019. Comparison of biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade: A systematic review and meta-analysis. JAMA Oncology 5(8):1195–1204.
Lucas, C. M., R. J. Harris, A. Giannoudis, M. Copland, J. R. Slupsky, and R. E. Clark. 2011. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Blood 117(24):6660–6668.
MacKay, M., E. Afshinnekoo, J. Rub, C. Hassan, M. Khunte, N. Baskaran, B. Owens, L. Liu, G. J. Roboz, M. L. Guzman, A. M. Melnick, S. Wu, and C. E. Mason. 2020. The therapeutic landscape for cells engineered with chimeric antigen receptors. Nature Biotechnology 38(2):233–244.
Maekawa, T., H. Tamura, H. Domon, T. Hiyoshi, T. Isono, D. Yonezawa, N. Hayashi, N. Takahashi, K. Tabeta, T. Maeda, M. Oda, A. Ziogas, V. I. Alexaki, T. Chavakis, Y. Terao, and G. Hajishengallis. 2020. Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1. Journal of Clinical Investigation Insight 5(15): e136706.
Maher, J., R. J. Brentjens, G. Gunset, I. Rivière, and M. Sadelain. 2002. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ/CD28 receptor. Nature Biotechnology 20(1):70–75.
Markworth, J. F., L. A. Brown, E. Lim, C. Floyd, J. Larouche, J. A. Castor-Macias, K. B. Sugg, D. C. Sarver, P. C. Macpherson, C. Davis, C. A. Aguilar, K. R. Maddipati, and S. V. Brooks. 2020. Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells. Journal of Clinical Investigation Insight 5(18):e137713.
Mauro, A. 1961. Satellite cell of skeletal muscle fibers. Journal of Biophysical and Biochemical Cytology 9(2):493–495.
Meizlish, M. L., R. A. Franklin, X. Zhou, and R. Medzhitov. 2021. Tissue homeostasis and inflammation. Annual Review of Immunology 39(1):557–581.
Menard, C., J. Dulong, D. Roulois, B. Hebraud, L. Verdiere, C. Pangault, V. Sibut, I. Bezier, N. Bescher, C. Monvoisin, M. Gadelorge, N. Bertheuil, E. Flecher, L. Casteilla, P. Collas, L. Sensebe, P. Bourin, N. Espagnolle, and K. Tarte. 2020. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells 38(1):146–159.
Menard, C., L. Pacelli, G. Bassi, J. Dulong, F. Bifari, I. Bezier, J. Zanoncello, M. Ricciardi, M. Latour, P. Bourin, H. Schrezenmeier, L. Sensebe, K. Tarte, and M. Krampera. 2013. Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: Standardization of immune quality controls. Stem Cells and Development 22(12):1789–1801.
Mo, F., N. Watanabe, M. K. McKenna, M. J. Hicks, M. Srinivasan, D. Gomes-Silva, E. Atilla, T. Smith, P. Ataca Atilla, R. Ma, D. Quach, H. E. Heslop, M. K. Brenner, and M. Mamonkin. 2021. Engineered off-the-shelf therapeutic T cells resist host immune rejection. Nature Biotechnology 39(1):56–63.
Moll, G., J. J. Alm, L. C. Davies, L. von Bahr, N. Heldring, L. Stenbeck-Funke, O. A. Hamad, R. Hinsch, L. Ignatowicz, M. Locke, H. Lonnies, J. D. Lambris, Y. Teramura, K. Nilsson-Ekdahl, B. Nilsson, and K. Le Blanc. 2014. Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? Stem Cells 32(9):2430–2442.
Moll, G., R. Jitschin, L. von Bahr, I. Rasmusson-Duprez, B. Sundberg, L. Lonnies, G. Elgue, K. Nilsson-Ekdahl, D. Mougiakakos, J. D. Lambris, O. Ringden, K. Le Blanc, and B. Nilsson. 2011. Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses. PLOS ONE 6(7):e21703.
Moll, G., I. Rasmusson-Duprez, L. von Bahr, A. M. Connolly-Andersen, G. Elgue, L. Funke, O. A. Hamad, H. Lonnies, P. U. Magnusson, J. Sanchez, Y. Teramura, K. Nilsson-Ekdahl, O. Ringden, O. Korsgren, B. Nilsson, and K. Le Blanc. 2012. Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells 30(7):1565–1574.
Moore, E. M., D. R. Maestas, C. C. Cherry, J. A. Garcia, H. Y. Comeau, L. Davenport Huyer, S. H. Kelly, A. N. Peña, R. L. Blosser, G. D. Rosson, and J. H. Elisseeff. 2021. Biomaterials direct functional B cell response in a material-specific manner. Science Advances 7(49):eabj5830.
Morris, H., S. DeWolf, H. Robins, B. Sprangers, S. A. LoCascio, B. A. Shonts, T. Kawai, W. Wong, S. Yang, J. Zuber, Y. Shen, and M. Sykes. 2015. Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients. Science Translational Medicine 7(272):272ra210.
NASEM (National Academies of Sciences, Engineering, and Medicine). 2020. Exploring novel clinical trial designs for gene-based therapies: Proceedings of a workshop. Edited by S. Addie, M. Hackmann, J. Alper, and S. H. Beachy. Washington, DC: The National Academies Press.
NASEM. 2021. Applying systems thinking to regenerative medicine: Proceedings of a workshop. Edited by S. Addie, M. Hackmann, L. Teferra, A. Nicholson, and S. H. Beachy. Washington, DC: The National Academies Press.
Nikolic, B., A. Khan, and M. Sykes. 2001. Induction of tolerance by mixed chimerism with nonmyeloblative host conditioning: The importance of overcoming intrathymic alloresistance. Biology of Blood and Marrow Transplantation 7(3):144–153.
Norling, L. V., M. Spite, R. Yang, R. J. Flower, M. Perretti, and C. N. Serhan. 2011. Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. Journal of Immunology 186(10):5543–5547.
Palla, A. R., M. Ravichandran, Y. X. Wang, L. Alexandrova, A. V. Yang, P. Kraft, C. A. Holbrook, C. M. Schurch, A. T. V. Ho, and H. M. Blau. 2021. Inhibition of prostaglandin-degrading enzyme 15-PGDH rejuvenates aged muscle mass and strength. Science 371(6528).
Palmer, A. K., B. Gustafson, J. L. Kirkland, and U. Smith. 2019. Cellular senescence: At the nexus between ageing and diabetes. Diabetologia 62(10):1835-1841.
Passweg, J. R., P. A. Rowlings, K. A. Atkinson, A. J. Barrett, R. P. Gale, A. Gratwohl, N. Jacobsen, J. P. Klein, P. Ljungman, J. A. Russell, U. W. Schaefer, K. A. Sobocinski, J. M. Vossen, M. J. Zhang, and M. M. Horowitz. 1998. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplantation 21(12):1231–1238.
Peled, J. U., A. L. C. Gomes, S. M. Devlin, E. R. Littmann, Y. Taur, A. D. Sung, D. Weber, D. Hashimoto, A. E. Slingerland, J. B. Slingerland, M. Maloy, A. G. Clurman, C. K. Stein-Thoeringer, K. A. Markey, M. D. Docampo, M. Burgos da Silva, N. Khan, A. Gessner, J. A. Messina, K. Romero, M. V. Lew, A. Bush, L. Bohannon, D. G. Brereton, E. Fontana, L. A. Amoretti, R. J. Wright, G. K. Armijo, Y. Shono, M. Sanchez-Escamilla, N. Castillo Flores, A. Alarcon Tomas, R. J. Lin, L. Yanez San Segundo, G. L. Shah, C. Cho, M. Scordo, I. Politikos, K. Hayasaka, Y. Hasegawa, B. Gyurkocza, D. M. Ponce, J. N. Barker, M. A. Perales, S. A. Giralt, R. R. Jenq, T. Teshima, N. J. Chao, E. Holler, J. B. Xavier, E. G. Pamer, and M. R. M. van den Brink. 2020. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. The New England Journal of Medicine 382(9):822–834.
Petersen, F. B., C. D. Buckner, R. A. Clift, N. Nelson, G. W. Counts, J. D. Meyers, and E. D. Thomas. 1987. Infectious complications in patients undergoing marrow transplantation: A prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics. Scandinavian Journal of Infectious Diseases 19(5):559–567.
Phelan, R., M. Arora, and M. Chen. 2020. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US Summary Slides.
Phillips, D., M. Matusiak, B. R. Gutierrez, S. S. Bhate, G. L. Barlow, S. Jiang, J. Demeter, K. S. Smythe, R. H. Pierce, S. P. Fling, N. Ramchurren, M. A. Cheever, Y. Goltsev, R. B. West, M. S. Khodadoust, Y. H. Kim, C. M. Schürch, and G. P. Nolan. 2021. Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma. Nature Communications 12(1).
Raimondo, T. M., and D. J. Mooney. 2018. Functional muscle recovery with nanoparticledirected M2 macrophage polarization in mice. Proceedings of the National Academy of Sciences of the United States of America 115(42):10648–10653.
Reategui, E., F. Jalali, A. H. Khankhel, E. Wong, H. Cho, J. Lee, C. N. Serhan, J. Dalli, H. Elliott, and D. Irimia. 2017. Microscale arrays for the profiling of start and stop signals coordinating human-neutrophil swarming. Nature Biomedical Engineering 1(7):0094.
Reynolds, G. 2017. Bring on the exercise, hold the painkillers. The New York Times, July 5, 2017.
Rieckmann, M., M. Delgobo, C. Gaal, L. Büchner, P. Steinau, D. Reshef, C. Gil-Cruz, E. N. T. Horst, M. Kircher, T. Reiter, K. G. Heinze, H. W. M. Niessen, P. A. J. Krijnen, A. M. Van Der Laan, J. J. Piek, C. Koch, H.-J. Wester, C. Lapa, W. R. Bauer, B. Ludewig, N. Friedman, S. Frantz, U. Hofmann, and G. C. Ramos. 2019. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses. Journal of Clinical Investigation 129(11):4922–4936.
Riviere, I., and M. Sadelain. 2017. Chimeric antigen receptors: A cell and gene therapy perspective. Molecular Therapy 25(5):1117–1124.
Russell, J. A., A. Chaudhry, K. Booth, C. Brown, R. C. Woodman, K. Valentine, D. Stewart, J. D. Ruether, B. A. Ruether, A. R. Jones, M. J. Coppes, T. Bowen, R. Anderson, M. Bouchard, L. Rallison, M. Stotts, and M. C. Poon. 2000. Early outcomes after allogeneic stem cell transplantation for leukemia and myelodysplasia without protective isolation: A 10-year experience. Biology of Blood and Marrow Transplantation 6(2):109–114.
Sadtler, K., K. Estrellas, B. W. Allen, M. T. Wolf, H. Fan, A. J. Tam, C. H. Patel, B. S. Luber, H. Wang, K. R. Wagner, J. D. Powell, F. Housseau, D. M. Pardoll, and J. H. Elisseeff. 2016. Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells. Science 352(6283):366–370.
Sadtler, K., M. T. Wolf, S. Ganguly, C. A. Moad, L. Chung, S. Majumdar, F. Housseau, D. M. Pardoll, and J. H. Elisseeff. 2019. Divergent immune responses to synthetic and biological scaffolds. Biomaterials 192:405–415.
Saetersmoen, M. L., Q. Hammer, B. Valamehr, D. S. Kaufman, and K. J. Malmberg. 2019. Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells. Seminars in Immunopathology 41(1):59–68.
Savage, T. M., B. A. Shonts, A. Obradovic, S. Dewolf, S. Lau, J. Zuber, M. T. Simpson, E. Berglund, J. Fu, S. Yang, S. H. Ho, Q. Tang, L. A. Turka, Y. Shen, and M. Sykes. 2018. Early expansion of donor-specific Tregs in tolerant kidney transplant recipients. JCI Insight 3(22).
Schurch, C. M., S. S. Bhate, G. L. Barlow, D. J. Phillips, L. Noti, I. Zlobec, P. Chu, S. Black, J. Demeter, D. R. McIlwain, S. Kinoshita, N. Samusik, Y. Goltsev, and G. P. Nolan. 2020. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell 182(5):1341–1359 e1319.
Schwabkey, Z. I., and R. R. Jenq. 2020. Microbiome anomalies in allogeneic hematopoietic cell transplantation. Annual Review of Medicine 71(1):137–148.
Serhan, C. N. 2014. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510(7503):92–101.
Serhan, C. N. 2017. Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms. FASEB Journal 31(4):1273–1288.
Serhan, C. N., N. Chiang, and J. Dalli. 2015. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution. Seminars in Immunology 27(3):200–215.
Serhan, C. N., N. Chiang, and J. Dalli. 2018. New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration. Molecular Aspects of Medicine 64:1–17.
Serhan, C. N., and B. D. Levy. 2018. Resolvins in inflammation: Emergence of the proresolving superfamily of mediators. Journal of Clinical Investigation 128(7):2657–2669.
Sharabi, Y., I. Aksentijevich, T. M. Sundt, 3rd, D. H. Sachs, and M. Sykes. 1990. Specific tolerance induction across a xenogeneic barrier: Production of mixed rat/mouse lymphohematopoietic chimeras using a nonlethal preparative regimen. Journal of Experimental Medicine 172(1):195–202.
Sharabi, Y., and D. H. Sachs. 1989. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. Journal of Experimental Medicine 169(2):493–502.
Sharma, B., S. Fermanian, M. Gibson, S. Unterman, D. A. Herzka, B. Cascio, J. Coburn, A. Y. Hui, N. Marcus, G. E. Gold, and J. H. Elisseeff. 2013. Human cartilage repair with a photoreactive adhesive-hydrogel composite. Science Translational Medicine 5(167):167ra166.
Shin, J., T. Maekawa, T. Abe, E. Hajishengallis, K. Hosur, K. Pyaram, I. Mitroulis, T. Chavakis, and G. Hajishengallis. 2015. DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. Science Translational Medicine 7(307):307ra155.
Sierra, F., A. Caspi, R. H. Fortinsky, L. Haynes, G. J. Lithgow, T. E. Moffitt, S. J. Olshansky, D. Perry, E. Verdin, and G. A. Kuchel. 2021. Moving geroscience from the bench to clinical care and health policy. Journal of the American Geriatrics Society 69(9):2455–2463.
Skalak, R., and C. F. Fox. 1988. “Tissue engineering: Proceedings of a workshop, held at Granlibakken, Lake Tahoe, California, February 26–29, 1988.”
Sommerfeld, S. D., C. Cherry, R. M. Schwab, L. Chung, D. R. Maestas, Jr., P. Laffont, J. E. Stein, A. Tam, S. Ganguly, F. Housseau, J. M. Taube, D. M. Pardoll, P. Cahan, and J. H. Elisseeff. 2019. Interleukin-36 -producing macrophages drive IL-17-mediated fibrosis. Science Immunology 4(40):eaax4783.
Sridharan, R., A. R. Cameron, D. J. Kelly, C. J. Kearney, and F. J. O’Brien. 2015. Biomaterial based modulation of macrophage polarization: A review and suggested design principles. Materials Today 18(6):313–325.
Stabler, C. L., J. A. Giraldo, D. M. Berman, K. M. Gattás Asfura, M. A. Willman, A. Rabassa, J. Geary, W. Diaz, N. M. Kenyon, and N. S. Kenyon. 2020. Transplantation of pegylated islets enhances therapeutic efficacy in a diabetic nonhuman primate model. American Journal of Transplantation 20(3):689–700.
Storb, R., R. L. Prentice, C. D. Buckner, R. A. Clift, F. Appelbaum, J. Deeg, K. Doney, J. A. Hansen, M. Mason, J. E. Sanders, J. Singer, K. M. Sullivan, R. P. Witherspoon, and E. D. Thomas. 1983. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. The New England Journal of Medicine 308(6):302–307.
Takeuchi, Y., H. Ito, J. Kurtz, T. Wekerle, L. Ho, and M. Sykes. 2004. Earlier low-dose TBI or DST overcomes CD8+ T-cell-mediated alloresistance to allogeneic marrow in recipients of anti-CD40L. American Journal of Transplantation 4(1):31–40.
Themeli, M., C. C. Kloss, G. Ciriello, V. D. Fedorov, F. Perna, M. Gonen, and M. Sadelain. 2013. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nature Biotechnology 31(10):928–933.
Tomita, Y., A. Khan, and M. Sykes. 1994. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. Journal of Immunology 153(3):1087–1098.
Tripathi, U., A. Misra, T. Tchkonia, and J. L. Kirkland. 2021. Impact of senescent cell subtypes on tissue dysfunction and repair: Importance and research questions. Mechanisms of Ageing and Development 198:111548.
Turner, T., M. Sok, L. Hymel, F. Pittman, W. York, Q. Mac, S. Vyshnya, H. Lim, G. Kwong, and P. Qiu. 2020. Harnessing lipid signaling pathways to target specialized pro-angiogenic neutrophil subsets for regenerative immunotherapy. Science Advances 6(44):eaba7702.
van Bekkum, D. W., J. Roodenburg, P. J. Heidt, and D. van der Waaij. 1974. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. Journal of the National Cancer Institute 52(2):401–404.
Van Dyke, T. E., H. Hasturk, A. Kantarci, M. O. Freire, D. Nguyen, J. Dalli, and C. N. Serhan. 2015. Proresolving nanomedicines activate bone regeneration in periodontitis. Journal of Dental Research 94(1):148–156.
Wagner, V., and J. Gil. 2020. T cells engineered to target senescence. Nature 583(7814):37–38.
Walsh, J. T., S. Hendrix, F. Boato, I. Smirnov, J. Zheng, J. R. Lukens, S. Gadani, D. Hechler, G. Gölz, K. Rosenberger, T. Kammertöns, J. Vogt, C. Vogelaar, V. Siffrin, A. Radjavi, A. Fernandez-Castaneda, A. Gaultier, R. Gold, T.-D. Kanneganti, R. Nitsch, F. Zipp, and J. Kipnis. 2015. MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. Journal of Clinical Investigation 125(2):699–714.
Wang, D. A., S. Varghese, B. Sharma, I. Strehin, S. Fermanian, J. Gorham, D. H. Fairbrother, B. Cascio, and J. H. Elisseeff. 2007. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nature Materials 6(5):385–392.
Wang, H., X. Li, T. Kajikawa, J. Shin, J. H. Lim, I. Kourtzelis, K. Nagai, J. M. Korostoff, S. Grossklaus, R. Naumann, T. Chavakis, and G. Hajishengallis. 2021. Stromal cell-derived DEL-1 inhibits TFH cell activation and inflammatory arthritis. Journal of Clinical Investigation 131(19).
Woan, K. V., H. Kim, R. Bjordahl, Z. B. Davis, S. Gaidarova, J. Goulding, B. Hancock, S. Mahmood, R. Abujarour, H. Wang, K. Tuininga, B. Zhang, C. Y. Wu, B. Kodal, M. Khaw, L. Bendzick, P. Rogers, M. Q. Ge, G. Bonello, M. Meza, M. Felices, J. Huffman, T. Dailey, T. T. Lee, B. Walcheck, K. J. Malmberg, B. R. Blazar, Y. T. Bryceson, B. Valamehr, J. S. Miller, and F. Cichocki. 2021. Harnessing features of adaptive NK cells to generate IPSC-derived NK cells for enhanced immunotherapy. Cell Stem Cell 28(12):2062–2075 e2065.
Xu, M., T. Pirtskhalava, J. N. Farr, B. M. Weigand, A. K. Palmer, M. M. Weivoda, C. L. In-man, M. B. Ogrodnik, C. M. Hachfeld, D. G. Fraser, J. L. Onken, K. O. Johnson, G. C. Verzosa, L. G. P. Langhi, M. Weigl, N. Giorgadze, N. K. LeBrasseur, J. D. Miller, D. Jurk, R. J. Singh, D. B. Allison, K. Ejima, G. B. Hubbard, Y. Ikeno, H. Cubro, V. D. Garovic, X. Hou, S. J. Weroha, P. D. Robbins, L. J. Niedernhofer, S. Khosla, T. Tchkonia, and J. L. Kirkland. 2018. Senolytics improve physical function and increase lifespan in old age. Nature Medicine 24(8):1246–1256.
Yamazaki, M., T. Pearson, M. A. Brehm, D. M. Miller, J. A. Mangada, T. G. Markees, L. D. Shultz, J. P. Mordes, A. A. Rossini, and D. L. Greiner. 2007. Different mechanisms control peripheral and central tolerance in hematopoietic chimeric mice. American Journal of Transplantation 7(7):1710–1721.
Yuh, D. Y., T. Maekawa, X. Li, T. Kajikawa, K. Bdeir, T. Chavakis, and G. Hajishengallis. 2020. The secreted protein DEL-1 activates a 3 integrin-FAK-ERK1/2-RUNX2 pathway and promotes osteogenic differentiation and bone regeneration. Journal of Biological Chemistry 295(21):7261–7273.
Zakrzewski, J. L., M. R. van den Brink, and J. A. Hubbell. 2014. Overcoming immunological barriers in regenerative medicine. Nature Biotechnology 32(8):786–794.
Zhou, X., R. A. Franklin, M. Adler, J. B. Jacox, W. Bailis, J. A. Shyer, R. A. Flavell, A. Mayo, U. Alon, and R. Medzhitov. 2018. Circuit design features of a stable two-cell system. Cell 172(4):744–757.e717.
Zhu, H., R. H. Blum, R. Bjordahl, S. Gaidarova, P. Rogers, T. T. Lee, R. Abujarour, G. B. Bonello, J. Wu, P.-F. Tsai, J. S. Miller, B. Walcheck, B. Valamehr, and D. S. Kaufman. 2020. Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity. Blood 135(6):399–410.
Zhu, Y., T. Tchkonia, T. Pirtskhalava, A. C. Gower, H. Ding, N. Giorgadze, A. K. Palmer, Y. Ikeno, G. B. Hubbard, M. Lenburg, S. P. O’Hara, N. F. LaRusso, J. D. Miller, C. M. Roos, G. C. Verzosa, N. K. LeBrasseur, J. D. Wren, J. N. Farr, S. Khosla, M. B. Stout, S. J. McGowan, H. Fuhrmann-Stroissnigg, A. U. Gurkar, J. Zhao, D. Colangelo, A. Dorronsoro, Y. Y. Ling, A. S. Barghouthy, D. C. Navarro, T. Sano, P. D. Robbins, L. J. Niedernhofer, and J. L. Kirkland. 2015. The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell 14(4):644–658.
Ziogas, A., T. Maekawa, J. R. Wiessner, T. T. Le, D. Sprott, M. Troullinaki, A. Neuwirth, V. Anastasopoulou, S. Grossklaus, K. J. Chung, M. Sperandio, T. Chavakis, G. Hajishengallis, and V. I. Alexaki. 2020. DHEA inhibits leukocyte recruitment through regulation of the integrin antagonist DEL-1. Journal of Immunology 204(5):1214–1224.
This page intentionally left blank.
